CJC-1295 No DAC 10mg

CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog that has been evaluated in research settings for its effects on endogenous growth hormone secretion. Studies indicate that it stimulates growth hormone release from the anterior pituitary and exhibits a longer functional half-life compared to native GHRH, allowing for more sustained signaling activity.

Research literature has examined CJC-1295 (No DAC) in relation to amino acid uptake, protein synthesis pathways, and markers associated with muscle tissue maintenance and recovery. Additional studies have explored its role in lipid metabolism, including the activation of lipolytic pathways and regulation of fat utilization in metabolic research models.

Investigations have also assessed its involvement in bone biology, particularly osteoblast activity and markers associated with bone turnover. Immunological studies have explored potential associations between growth hormone signaling and immune cell activity.

Further research has examined the role of GHRH analogs in regulating growth hormone secretion patterns, circadian rhythm interactions, sleep-related biomarkers, and age-associated physiological changes within controlled study environments.

This peptide is supplied as a lyophilized powder to support stability for laboratory and research use.